Obesity
Not yet recruitingKAI-9531 in Adults With Obesity or Overweight and Diabetes
KAI-9531 in Adults With Obesity or Overweight and Diabetes
Hungary- Participants:18–64 years · 65+ years
- Substances:HRS 9531
- Sponsor:Kailera Therapeutics Inc.
Rare diseases
Investigational molecules
Locations
Back to Hungary1 101 clinical trials in Kistarcsa, Hungary. Every trial is listed in the EU Clinical Trials Register and updated daily.
KAI-9531 in Adults With Obesity or Overweight and Diabetes
HungaryA study to evaluate the effect of muvalaplin on reducing major cardiovascular events in adults with high levels of lipoprotein(a) and atherosclerotic cardiovascular disease.
HungaryA study to evaluate the effectiveness and safety of JNJ-88545223 in people with active psoriatic arthritis
HungaryA study to evaluate the long-term safety and effectiveness of sonelokimab in patients with psoriatic arthritis
HungaryStudy of telitacicept compared to placebo in adults with moderate to severe systemic lupus erythematosus
HungaryStudy of IMG-007 injection to treat moderate to severe atopic dermatitis in adults
HungaryStudy of N-803, tislelizumab and docetaxel combination versus docetaxel alone for patients with advanced or metastatic non-small cell lung cancer resistant to immune checkpoint inhibitors
HungaryStudy of olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)
HungaryStudy on the Effectiveness and Safety of BHV-7000 for Adults with Refractory Focal Onset Epilepsy
HungaryStudy comparing MB04 (etanercept biosimilar) with Enbrel in patients with moderate to severe rheumatoid arthritis who are taking methotrexate
HungaryStudy on TAK-861 for Treating Narcolepsy with Cataplexy in Patients
HungaryStudy on the Effectiveness and Safety of JNJ-77242113 and Deucravacitinib for Adults with Moderate to Severe Plaque Psoriasis
HungaryThe busiest research cities in the country
What the registry says about research in the country
Multiple clinical trials focusing on psoriatic arthritis and rheumatoid arthritis treatments, evaluating new therapeutic approaches for inflammatory joint conditions.
Research includes assessment of novel biologics and comparative effectiveness studies.
Innovative trials targeting atherosclerotic cardiovascular disease and various cardiovascular conditions, including studies on clot prevention and heart failure.
Focus on both preventive measures and therapeutic interventions for cardiovascular health.
Advanced research in multiple sclerosis treatment, particularly focusing on primary progressive MS and innovative therapeutic approaches.
Emphasis on long-term disease management and quality of life improvement.
Studies addressing type 2 diabetes, obesity, and chronic kidney disease, exploring new treatment options and management strategies.
Investigation of novel therapies for metabolic disorders and their complications.
Tell us about your condition – we search every trial in Europe and connect you with the right site.